ANTIANGIOGENIC GENE THERAPY WITH SOLUBLE VEGFR-2 AND TIE2 REDUCES THE GROWTH OF HUMAN OVARIAN CARCINOMA IN MICE

被引：0
|
作者：
Tuppurainen, L. [1 ]
Sallinen, H. [2 ]
Karvonen, A. [1 ]
Hakkarainen, H. [3 ]
Liimatainen, T. [3 ]
Hytonen, E. [1 ]
Hamalainen, K. [4 ]
Kosma, V. M. [4 ]
Anttila, M. [2 ]
Alitalo, K. [5 ,6 ]
Yla-Herttuala, S. [1 ]
机构：
[1] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio, Finland
[2] Kuopio Univ Hosp, Dept Gynecol, SF-70210 Kuopio, Finland
[3] Univ Eastern Finland, NMR Res Grp, AI Virtanen Inst Mol Sci, Kuopio, Finland
[4] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland
[5] Univ Helsinki, Mol Canc Biol Lab, Biomedicum Helsinki, Helsinki, Finland
[6] Univ Helsinki, Haartman Inst, Helsinki, Finland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1277
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [31] Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
    Sallinen, Hanna
    Heikura, Tommi
    Koponen, Jonna
    Kosma, Veli-Matti
    Heinonen, Seppo
    Yia-Herttuala, Seppo
    Anttila, Maarit
    BMC CANCER, 2014, 14
  • [32] Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer
    Hata, K
    Nakayama, K
    Fujiwaki, R
    Katabuchi, H
    Okamura, H
    Miyazaki, K
    GYNECOLOGIC ONCOLOGY, 2004, 93 (01) : 215 - 222
  • [33] Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy
    Wu, Xianghua
    Li, Zonghai
    Yao, Ming
    Wang, Huamao
    Qu, Sumin
    Chen, Xianlian
    Li, Jinjun
    Sun, Ye
    Xu, Yuhong
    Gu, Jianren
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2008, 40 (03) : 217 - 225
  • [34] Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
    Hanna Sallinen
    Tommi Heikura
    Jonna Koponen
    Veli-Matti Kosma
    Seppo Heinonen
    Seppo Ylä-Herttuala
    Maarit Anttila
    BMC Cancer, 14
  • [35] Attenuation of VEGFR-2 Expression by Soluble VEGFR-1 (sFlt-1) and Hypoxia in the Human Placenta
    Lee, Dennis K.
    Caniggia, Isabella
    Nevo, Ori
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 324A - 324A
  • [36] Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice
    Tuppurainen, Laura
    Sallinen, Hanna
    Karvonen, Anni
    Valkonen, Elina
    Laakso, Hanne
    Liimatainen, Timo
    Hytonen, Elisa
    Hamalainen, Kirsi
    Kosma, Veli-Matti
    Anttila, Maarit
    Yla-Herttuala, Seppo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 879 - 886
  • [37] Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer
    Cybulski, Marek
    Jarosz, Bozena
    Nowakowski, Andrzej
    Jeleniewicz, Witold
    Seroczynski, Przemyslaw
    Mazurek-Kociubowska, Magdalena
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 217 - 222
  • [38] High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer
    Makhoul, Issam
    Griffin, Robert J.
    Siegel, Eric
    Lee, Jeannette
    Dhakal, Ishwori
    Raj, Vinay
    Jamshidi-Parsian, Azemat
    Klimberg, Suzanne
    Hutchins, Laura F.
    Kadlubar, Susan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (03): : 248 - 254
  • [39] Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
    Dias, S
    Hattori, K
    Zhu, ZP
    Heissig, B
    Choy, M
    Lane, W
    Wu, Y
    Chadburn, A
    Hyjek, E
    Gill, M
    Hicklin, DJ
    Witte, L
    Moore, MAS
    Rafii, S
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04): : 511 - 521
  • [40] Expression and localization of VEGFR-2 in hair follicles during induced hair growth in mice
    Wu, Xian-Jie
    Jing, Jing
    Lu, Zhong-Fa
    Zheng, Min
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2018, 310 (07) : 591 - 598
12345